Fresh analysis suggests that people who discontinue new weight-loss injections like semaglutide or tirzepatide can put back on shed pounds far faster than those who halt conventional lifestyle plans.
Research printed in a prominent medical journal demonstrates that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the weight returns at an average rate of 0.8 kg per month upon discontinuation.
"People using such medications should be aware of the potential of quick weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.
That rate of recovery means a return to pre-treatment weight within about a year and a half.
Comparing Treatments
The analysis, which reviewed dozens of studies involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with older methods.
Scientists note that individuals who shed pounds through lifestyle changes alone typically see a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Rapid Rebound
Nutrition scientists suggest the mode of action of the drugs explains the accelerated weight return.
These medications copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of the hormone concentrations far above than the body's typical production may cause the body to produce less of its endogenous hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication leads to appetite is unsuppressed, making excessive eating a significant risk."
An Ongoing Issue?
Health authorities suggest the injections for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Professionals say that, due to the high risk of weight regain, the therapy should be considered long-term.
This view is echoed by pharmaceutical companies, who note that the findings "emphasize the chronic nature of excess weight," akin to managing conditions like diabetes.
Patient Testimonies
Users who have come off the medication explain a powerful resurgence of hunger.
"I experienced a switch flipping and you become extremely hungry," recalled a patient.
This difficulty is compounded if individuals have not established lasting lifestyle or habit changes during treatment.
Significant Interest
Survey data suggest that millions of adults in the UK have tried these injections in the past year, with demand continuing to grow.
- Use is more common among females than males.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while these medications are powerful tools for shedding pounds, they are not a permanent cure and lasting health benefits hinges on combined behavioural support.
